Substance Use: Clinical Trials

3 trials for Substance Use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Recruiting 1, Terminated 1

Follow Substance Use: new trials by email Literature Review of Substance Use trials Research Report on Substance Use

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ANCHORS Alcohol & Sexual Health Study: UH3 Project
PrEP acronym (pre-exposure prophylaxis), Initial Web Survey, Interactive Voice Response (IVR) monitoring - Alcohol Use, Unspecified, Substance Use
Phase 4RecruitingUniversity of Florida882021-01-122025-07-10
Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder
Vivitrol (Extended Release Naltrexone) - Alcohol Use Disorder, Substance Use
Phase 4TerminatedUniversity of California, San Francisco1792020-08-142023-06-22
Creatine as a Treatment Option for Depression in Methamphetamine Using Females
Creatine monohydrate - Depression, Substance Abuse
Phase 4CompletedPerry Renshaw142013-01-012015-06-29

Narrower conditions

Substance-Related Disorders (3)  ·  Alcohol Drinking (1)  ·  Alcoholism (1)  ·  Depression (1)  ·  Emergencies (1)  ·  Sexual Behavior (1)

Broader conditions

Chemically-Induced Disorders (3)  ·  Mental Disorders (3)  ·  Behavior (2)  ·  Alcohol-Related Disorders (1)  ·  Behavioral Symptoms (1)  ·  Disease Attributes (1)  ·  Drinking Behavior (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Case Management (1)  ·  Creatine (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Ethanol (1)  ·  Pre-Exposure Prophylaxis (1)  ·  Restraint, Physical (1)  ·  vivitrol (1)

Sponsors

Perry Renshaw (1)  ·  University of California, San Francisco (1)  ·  University of Florida (1)

Countries

United States (3)

Top investigators

Charles E Murphy IV, MD (1)  ·  Maria Raven, MD (1)  ·  Perry Renshaw, MD, PhD, MBA (1)  ·  Robert L. Cook, PhD (1)  ·  Tracy Hellem, RN (1)

Results publications

PMID 26457568, PMID 36328851

NIH funding

F31AA028751 (1), UH3AA026214 (1)